An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (2)
  • Publications (98)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (10)
  • White paper (1)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • Gastro-intestinal (125)
  • Genito-urinary (51)
  • Gynecological (7)
  • Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • (-) Ocular (12)
  • (-) Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)
  • Reset filters
  • (-) Ocular
  • (-) Pediatric

Long-term Health Related Quality of Life in Pediatric Brain Tumor Survivors Treated with Proton Radiotherapy at <4 Years of Age.

01/09/2020
/ Publications
/
Quality of life

Fifty-nine brain tumor children 4 years old received PRT were followed for the median 9.1 years (5.5-18 years). The report of long-term health related quality...

The role of proton therapy in pediatric malignancies: Recent advances and future directions.

03/02/2020
/ Publications
/
Toxicity

This systematic review provides latest outcomes data after proton therapy across the common pediatric disease sites.

It discusses the main attempts to assess...

Outcomes following limited-volume proton therapy for multifocal spinal myxopapillary ependymoma

10/11/2020
/ Publications
/
Toxicity

A study by the Jacksonville group reported the disease control and toxicity in 12 pediatric patients with multifocal spinal myxopapillary ependymoma (MPE)...

Neurocognitive impairment following PT for paediatric brain tumour

10/10/2020
/ Publications

In comparing cognitive changes after radiotherapy for pediatric brain tumors, this review reported significantly poorer cognitive outcome among patients treated...

Second tumor risk in children treated with proton therapy.

04/02/2021
/ Publications
/
Secondary cancer

Published in Pediatric Blood & Cancer, this study by the Jacksonville group evaluated the secondary tumor risk based on the data of 1713 children that underwent...

Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma.

07/09/2019
/ Publications
/
Chemotherapy
Survival

A study by the Jacksonville group. Seventeen patients with nonmetastatic nasopharyngeal carcinoma underwent double-scattered proton therapy. With the median...

Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.

07/07/2019
/ Publications
/
VMAT

40 patients treated with PBT were selected for VMAT re-plan. The VMAT and delivered PT plans were compared by dose/volume metrics and NTCP models related to...

Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma (B/P-RMS).

07/08/2019
/ Publications
/
Toxicity

This study reported outcomes of 19 patients of B/P-RMS treated with PBT. With a median follow-up of 66.2 months, 5-year overall survival (OS) and progression...

Outcome and patterns of relapse in childhood parameningeal rhabdomyosarcoma treated with PBT.

07/08/2019
/ Publications

Published in the Red Journal, the study by WPE reported outcomes of PBT for 46 pediatric patients with parameningeal rhabdomyosarcoma (pRMS). Wit a median...

Practice patterns among radiation oncologists treating pediatric patients with proton craniospinal irradiation.

07/07/2019
/ Publications

This survey study aimed to assess current practice patterns regarding the vertebral bodies (VB) coverage for pediatric patients undergoing CSI. With the 28...

Pagination

  • Previous page ‹
    • Page 2
    • Current page 3
    • Page 4
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies